Syndax Pharmaceuticals SNDX Balance Sheet (2015-2026)

NASDAQ SNDX
$9.43 -0.06 (-0.63%)
As of: Nov 11, 2026 · 9:36 AM EST
Reported Financials

Syndax Pharmaceuticals Quarterly Balance Sheet

Periods 47 quarters
Latest Sep 2026

Syndax Pharmaceuticals reported total assets of $692.67M and total liabilities of $709.85M for the quarter ended Sep 2026, up 25.5% year over year. This balance sheet covers 47 quarters of results from Mar 2015 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
222.08M188.89M120.35M71.49M74.36M57.52M97.28M94.55M295.39M114.62M105.40M133.02M154.08M153.99M108.64M116.81M134.93M130.89M336.48M135.94M
Short-term InvestmentsInvestments (Current)
217.97M209.16M246.55M266.46M401.45M374.88M301.53M269.01M275.30M319.96M319.70M256.59M418.80M358.20M346.60M319.17M259.14M221.17M211.38M291.16M
Cash & Current Investments
440.05M398.05M366.91M337.95M475.80M432.39M398.80M363.56M570.70M434.58M425.10M389.61M572.88M512.20M455.23M435.98M394.07M352.06M547.86M427.10M
Receivables - NetNet Receivables
7.60M15.72M19.45M25.40M38.00M38.12M45.07M46.87M
Receivables - OtherOther Receivables
13.10M4.54M3.47M1.39M3.41M4.00M3.50M3.50M3.64M10.30M33.20M20.90M28.10M24.70M26.40M65.40M
Receivables
11.24M26.02M52.65M46.30M66.10M62.82M71.47M112.27M
Raw Materials
1.74M14.18M21.40M29.03M30.70M29.20M34.87M
Work In Process
0.33M0.57M1.28M1.38M2.11M2.87M2.43M3.34M
Finished Goods
0.04M2.35M2.25M2.22M1.62M1.38M1.53M1.17M
Inventory
0.37M4.66M17.70M25.00M32.75M34.95M33.16M39.38M
Prepaid Assets
1.45M9.03M2.39M2.27M1.92M1.91M3.06M3.75M3.29M4.67M4.21M4.91M8.54M8.46M9.88M9.52M13.50M16.10M17.48M14.09M
Current Assets
448.40M420.06M392.29M357.63M489.79M441.51M409.08M380.97M580.88M453.90M446.06M414.81M603.06M548.75M531.68M529.83M528.08M471.18M675.04M567.44M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.28M0.27M0.26M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.00M0.13M0.18M0.18M0.21M0.21M
Long-Term Investments
12.13M5.47M16.56M19.48M15.71M29.83M87.42M29.52M10.03M119.52M89.94M62.63M20.15M27.22M123.98M
Intangibles
0.98M1.04M1.49M2.02M1.34M
Goodwill & Intangibles
0.98M1.04M1.49M2.02M1.34M
Other Non-Current Assets
0.12M1.14M1.11M1.00M0.92M0.81M0.80M0.80M0.68M0.47M0.37M0.22M0.22M0.22M0.22M0.22M0.10M0.10M0.10M0.10M
Non-Current Assets
1.26M2.17M14.15M2.06M7.45M18.32M22.26M18.25M32.00M89.13M30.89M11.00M121.76M91.96M64.47M21.96M1.63M1.49M28.61M125.24M
Assets
449.66M422.22M406.44M359.69M497.24M459.83M431.34M399.22M612.88M543.03M476.95M425.81M724.82M640.71M596.15M551.79M529.71M472.67M703.65M692.67M
Liabilities
Current Liabilities
Accounts Payables
5.67M8.23M6.44M7.12M4.35M8.06M10.98M6.05M9.96M8.81M11.57M4.90M11.63M10.05M17.35M13.83M16.58M10.84M4.87M3.57M
Notes Payables
306.77M321.63M160.81M263.95M
Payables
312.44M8.23M6.44M7.12M325.98M8.06M10.98M6.05M170.77M8.81M11.57M4.90M275.58M10.05M17.35M13.83M16.58M10.84M4.87M3.57M
Accumulated Expenses
14.47M18.42M16.97M13.21M24.28M15.21M17.73M32.12M39.86M33.40M26.81M48.12M60.10M55.98M71.07M77.11M103.06M74.84M94.30M116.86M
Other Accumulated Expenses
1.70M1.89M3.17M3.19M0.60M0.70M0.53M0.77M0.89M1.08M0.22M0.21M0.42M0.58M0.62M0.60M0.72M1.27M1.55M1.96M
Short term Debt
3.57M7.21M12.12M
Current Leases
0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M
Current Deferred Revenue
Total Current Liabilities
20.68M30.55M30.93M20.80M29.07M23.72M30.17M39.17M58.10M50.81M42.47M59.38M103.55M94.55M112.99M114.19M120.12M86.17M99.68M120.96M
Non-Current Liabilities
Capital Leases
0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.00M0.00M1.58M1.45M1.33M1.19M1.05M0.91M0.76M0.61M
Non-Current Debt
19.90M16.48M12.99M331.57M329.64M324.41M320.99M343.91M343.97M344.03M344.10M
Convertible Debt
-0.39M-0.19M244.09M244.19M
Non-Current Deferred Revenue
Preferred Stock Liabilities
Operating Leases
0.71M0.64M0.57M0.77M0.71M0.59M1.12M0.85M0.58M0.33M0.13M1.58M0.38M1.33M1.19M1.05M0.91M0.76M0.61M
Other Non-Current Liabilities
0.19M
Total Non-Current Liabilities
20.61M17.12M13.57M0.78M0.72M0.60M1.13M0.86M0.59M0.33M0.14M0.00M333.14M331.10M325.74M322.18M344.96M344.87M588.88M588.89M
Total Liabilities
41.29M47.67M44.50M21.59M29.79M24.32M31.30M40.04M58.68M51.14M42.61M59.38M436.69M425.65M438.73M436.36M465.08M431.05M688.55M709.85M
Shareholder's Equity
Total Debt
326.66M20.05M20.21M321.63M160.81M607.63M329.64M324.41M320.99M343.91M343.97M344.03M344.10M
Common Equity
408.37M374.55M361.94M338.10M467.45M435.51M400.04M359.19M554.20M491.89M434.34M366.43M288.12M215.06M157.42M115.43M64.63M41.62M15.10M-17.18M
Liabilities and Shareholders Equity
449.66M422.22M406.44M359.69M497.24M459.83M431.34M399.22M612.88M543.03M476.95M425.81M724.82M640.71M596.15M551.79M529.71M472.67M703.65M692.67M
Retained Earnings
-543.70M-580.87M-618.44M-653.85M-693.04M-734.17M-778.78M-829.93M-902.40M-974.80M-1,042.86M-1,126.99M-1,221.16M-1,306.00M-1,377.85M-1,438.57M-1,506.58M-1,549.25M-1,598.62M-1,648.05M
Treasury Shares
14.21M64.76M68.16M234.16M

Syndax Pharmaceuticals Balance Sheet API

Pull Syndax Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SNDX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY